Where it is registered
Each register with its number of medicines and a few of them.
Netherlands
CBG-MEB · 90 medicines
- Carbidopa/Levodopa Brillpharma 10mg/100mg, tablettenTablet · Brillpharma (Ireland) Limited
- Carbidopa/Levodopa Brillpharma 12,5mg/50mg, tablettenTablet · Brillpharma (Ireland) Limited
- Carbidopa/Levodopa Brillpharma 25mg/100mg, tablettenTablet · Brillpharma (Ireland) Limited
- Carbidopa/Levodopa Brillpharma 25mg/250mg, tablettenTablet · Brillpharma (Ireland) Limited
Spain
AEMPS · 81 medicines
- Carbidopa/Levodopa Kern Pharma 25 MG/100 MG Comprimidos Efg27 mg + 100 mg · comprimido · Kern Pharma S.L.
- Carbidopa/Levodopa Kern Pharma 25 MG/250 MG Comprimidos Efg27 mg + 250 mg · comprimido · Kern Pharma S.L.
- Doporio 25 MG/250 MG Comprimidos Efg250 mg + 27 mg · comprimido · Orion Corporation
- Doporio 25MG/100 MG Comprimidos Efg100 mg + 27 mg · comprimido · Orion Corporation
Canada
All medicines with Carbidopa
Every register, a page at a time. Strengths and packs are on each medicine’s page.
24 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Carbidopa | United States | 25MG | tablet | Marketed | Zydus Pharms |
| Carbidopa and LevodopaCombination | United States | 10MG; 100MG, 25MG; 100MG, 25MG; 250MG | tablet, orally disintegrating | Marketed | Rising |
| Carbidopa and LevodopaCombination | United States | 25MG; 100MG, 50MG; 200MG | tablet, extended release | Marketed | Accord Hlthcare |
| Carbidopa and LevodopaCombination | United States | 10MG; 100MG, 25MG; 100MG, 25MG; 250MG | tablet | Marketed | Apotex INC |
| Carbidopa, Levodopa and EntacaponeCombination | United States | 12.5MG; 200MG; 50MG, 18.75MG; 200MG; 75MG, 25MG; 200MG; 100MG … | tablet | Marketed | Sun Pharm |
| Carbidopa; LeodopaCombination | United States | 145MG, 195MG, 23.75MG … | capsule, extended release | Tentative approval | Zydus Pharms USA INC |
| Carbidopa; LevodopaCombination | United States | 23.75MG; 95MG, 36.25MG; 145MG, 48.75MG; 195MG … | capsule, extended release | Tentative approval | Sandoz INC |
| Carbidopa and LevodopaCombination | United States | 140MG, 145MG, 195MG … | capsule, extended release | Tentative approval | DR Reddys Labs LTD |
| Carbidopa and LevodopaCombination | United States | 145MG, 195MG, 23.75MG … | capsule, extended release | Tentative approval | Biocon Pharma Limited |
| DuopaCombination | United States | 4.63MG/ML; 20MG/ML | suspension | Marketed | Abbvie |
| CarbilevCombination | United States | 10MG; 100MG, 25MG; 100MG, 25MG; 250MG | tablet, for suspension | Not marketed | Ranbaxy |
| CrexontCombination | United States | 35MG; 140MG, 52.5MG; 210MG, 70MG; 280MG … | capsule, extended release | Marketed | Impax |
| DhivyCombination | United States | 25MG; 100MG | tablet | Marketed | Avion Pharms |
| Lodosyn | United States | 25MG | tablet | Marketed | Aton |
| RytaryCombination | United States | 23.75MG; 95MG, 36.25MG; 145MG, 48.75MG; 195MG … | capsule, extended release | Marketed | Impax |
| SinemetCombination | United States | 10MG; 100MG, 25MG; 100MG, 25MG; 250MG | tablet | Marketed | Organon |
| Stalevo 100Combination | United States | 25MG; 200MG; 100MG | tablet | Marketed | Orion Pharma |
| Stalevo 125Combination | United States | 31.25MG; 200MG; 125MG | tablet | Marketed | Orion Pharma |
| Stalevo 150Combination | United States | 37.5MG; 200MG; 150MG | tablet | Marketed | Orion Pharma |
| Stalevo 200Combination | United States | 50MG; 200MG; 200MG | tablet | Marketed | Orion Pharma |
| Stalevo 50Combination | United States | 12.5MG; 200MG; 50MG | tablet | Marketed | Orion Pharma |
| Stalevo 75Combination | United States | 18.75MG; 200MG; 75MG | tablet | Marketed | Orion Pharma |
| ParcopaCombination | United States | 10MG; 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 25MG; 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 25MG; 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, orally disintegrating | Not marketed | Ucb INC |
| Sinemet CRCombination | United States | 25MG; 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 50MG; 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, extended release | Not marketed | Organon LLC |
Brand names
The same brand on several registers.
- Stalevo🇧🇷 🇨🇦 🇪🇸 🇪🇺 🇭🇷 🇮🇹 🇳🇱 🇳🇿 🇷🇸 🇸🇦 🇸🇬 🇹🇼 🇺🇸 · 13 registers
- Sinemet🇧🇷 🇨🇦 🇪🇸 🇮🇹 🇳🇱 🇳🇿 🇸🇦 🇺🇸 · 8 registers
- Duodopa🇧🇷 🇨🇦 🇪🇸 🇭🇷 🇳🇱 🇷🇴 🇸🇦 · 7 registers
- Corbilta🇪🇺 🇭🇷 🇮🇹 🇳🇱 · 4 registers
- Hopledo🇪🇸 🇭🇷 🇳🇱 · 3 registers
- Doporio 12,5 mg/50 mg tabletten🇪🇸 🇭🇷 🇳🇱 · 3 registers
- Lecigon 20 MG/ML + 5 MG/ML + 20 MG/ML Gel Intestinal🇪🇸 🇭🇷 🇳🇱 · 3 registers
- Onerji🇪🇺 🇭🇷 🇳🇱 · 3 registers
- SASTRAVI 100 mg/25 mg/200 mg🇷🇴 · 1 register
- Sandoz Levodopa-Carbidopa-Entacapone🇨🇦 · 1 register
- TRIGELAN 100 mg/25 mg/200 mg🇷🇴 · 1 register
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Names in the registers
How the registers write it, in their own languages.
- Carbidopum
- Karbidopa
Sources
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 14
- Medicines
- 362
- Companies
- 105